Marilyn E. Smalley, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 803 N Brady St, Abilene, KS 67410 Phone: 785-263-4765 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today preliminary clinical data from its ongoing Phase I trial with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.
A simple non-surgical gum disease treatment markedly reduces the thickness of the wall of the arteries, a risk factor for heart disease, according to a first of its kind study among Aboriginal Australians.
The risk factors for severe COVID-19 have been established on the basis of observational studies. However, SARS-CoV-2 continues to cause thousands of COVID-19 cases all over the world, and the risk factors are unclear. A new study deals with this aspect of the pandemic.
A scientific team led by Brian Brown, PhD, Professor of Genetics and Genomic Sciences and Associate Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (New York, New York), has been awarded $500,000 from Alliance for Cancer Gene Therapy to advance a promising immunotherapy approach to fight lung cancer and other solid tumor cancers.
The vast majority (97.4%) of players with the Spanish League are unfamiliar with the list of substances banned by the World Anti-Doping Agency (WADA). Furthermore, 95% do not even know what this agency is for.
› Verified 3 days ago